查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363026

分子细胞遗传学市场规模、份额、趋势分析报告：按用途、按技术、按产品、按最终用途、按地区、细分市场趋势，2023-2030 年

Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Oncology, Personalized Medicine), By Technology (FISH, Immunohistochemistry, Karyotyping), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 236 Pages | 商品交期: 2-10个工作天内

价格

分子细胞遗传学市场成长与趋势：

Grand View Research 的最新报告显示，到 2030 年，全球分子细胞遗传学市场预计将达到 44.6 亿美元。

预计2023年至2030年该市场将以10.6%的年复合成长率扩张。分子细胞遗传学在临床病理学检测中的渗透率不断提高、对标靶癌症治疗的倾向不断增加以及对个人化医疗的日益关注是推动成长的关键要素。此外，遗传疾病罹患率的增加、分子细胞遗传学领域的技术进步以及研发活动的活性化预计将在预测期内推动市场扩张。

此外，透过整合高通量测序进行的细胞遗传学分析也是预计在未来年度显着促进成长的要素之一。许多科学家和研究人员已经整合了NGS和细胞遗传学实验室，它们相互相容。因此，由于序列价格大幅下降，预计市场将以相当大的速度成长。

COVID-19的爆发对分子细胞遗传学市场产生了积极影响。由于检测优先顺序发生变化，分子细胞遗传学实验室已转向执行 COVID-19 诊断检测。此外，对公共卫生基因组学的日益关注凸显了分子细胞遗传学在基于人群的基因组监测和追踪疾病传播中的价值，有助于制定有效的公共卫生策略。因此，大流行期间诊断测试的高发生率正在推动分子细胞遗传学市场的成长。

症候群、地中海贫血和囊性纤维化等遗传性疾病发病率的增加预计将在预测期内推动该领域的成长。例如，世界卫生组织估计，每 1,000 人中约有 10 人罹患遗传疾病，相当于全世界约 7,000 至 8,000 万人。此外，营运商针对细胞遗传学工具技术进步的策略性倡议不断增加，预计将推动分子细胞遗传学市场的发展。例如，2022 年 10 月，Genoox 与 Thermo Fisher Scientific 合作推出了 CytoScan 自动解释和报告 (AIR) 解决方案。该工具有望促进细胞遗传学研究资料分析。

分子细胞遗传学市场报告亮点

  • 从用途来看，2022年肿瘤领域占据市场主导地位，份额为39.70%。这是因为 CGH 技术可以对癌症发病机制进行详细研究。
  • 从按产品来看，由于人们对遗传疾病和个人化医疗的了解和认识不断增强，2022年消耗品将占39.51%的份额。
  • 从技术面来看，由于更好的染色体分析技术不断进步，比较基因组杂交领域将在 2022 年主导分子细胞遗传学市场。
  • 按最终用途，临床和研究实验室部门占 2022 年收益占有率的大部分。同时，製药和生物公司领域预计在预测期内将呈现最快的年复合成长率。
  • 2022年，由于技术进步、医疗保健基础设施改善、大型企业的存在以及该地区药物临床试验及其核准数量的增加，北美在该行业中占据主导地位。

目录

第1章分子细胞遗传学市场：调查方法与范围

第2章细胞遗传学市场：执行摘要

  • 市场预测
  • 应用和技术简介
  • 产品和最终用途简介
  • 竞争形势概览

第3章分子细胞遗传学市场：市场变数、趋势与范围

  • 市场体系预测
  • 市场动态
  • 产业分析工具

第4章分子细胞遗传学市场：用途的商业分析

  • 分子细胞遗传学市场：用途变异分析
  • 遗传疾病
  • 肿瘤学
  • 个人化医疗
  • 其他用途

第5章分子细胞遗传学市场：技术的商业分析

  • 分子细胞遗传学市场：技术变异分析
  • 比较基因组杂交
  • FISH
  • 免疫组织化学
  • 核型分析
  • 其他的

第6章分子细胞遗传学市场：产品业务分析

  • 分子细胞遗传学市场：产品变异分析
  • 装置
  • 消耗品
  • 软体和服务

第7章分子细胞遗传学市场：最终用途业务分析

  • 分子细胞遗传学市场：最终用途变异分析
  • 临床及研究机构
  • 医院和路径实验室
  • 学术研究所
  • 製药和生物技术公司
  • 其他的

第8章细胞遗传学市场：区域业务分析

  • 区域市场简介
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章分子细胞遗传学市场：竞争形势

  • 公司分类
  • 策略规划
  • 2022 年公司市场占有率分析
  • 公司简介

第10章KOL推荐/分析师观点

Product Code: GVR-1-68038-023-1

Molecular Cytogenetics Market Growth & Trends:

The global molecular cytogenetics market size is anticipated to reach USD 4.46 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 10.6% from 2023 to 2030. Rising penetration of molecular cytogenetics in clinical pathological testing, growing inclination towards targeted cancer treatment, and increasing focus on personalized medicine are the key factors driving growth. In addition, the increasing incidence of genetic disorders, technological advancements in the field of molecular cytogenetics, and rising R&D activities are anticipated to drive market expansion over the forecast period.

Furthermore, the cytogenetic analysis carried out through the integration of high throughput sequencers is another factor that is expected to significantly boost growth in the coming years. A number of scientists and researchers integrate NGS with cytogenetics laboratories as they are compliant with one another. Thus, with a significant drop in sequencing prices, the market is estimated to grow at a substantial pace.

The COVID-19 pandemic has positively impacted the market for molecular cytogenetics. Due to the shift in testing priorities, molecular cytogenetics laboratories were being redirected to conduct COVID-19 diagnostic testing. Furthermore, the increased focus on public health genomics has highlighted the value of molecular cytogenetics in population-based genomic surveillance and tracking disease spread, contributing to the development of effective public health strategies. Thus, the high incidence of diagnostic testing during the pandemic has fueled the growth of the market for molecular cytogenetics.

Increasing incidences of genetic disorders such as Down syndrome, Thalassemia, and Cystic Fibrosis are anticipated to fuel segment growth during the projected timeframe. For instance, according to WHO estimates, about 10 out of every 1000 people are affected with genetic disorders, which is approximately 70-80 million people globally. Moreover, rising strategic initiatives by operating players for technological advancements in cytogenetic tools are projected to propel the market for molecular cytogenetics. For instance, in October 2022, Genoox partnered with Thermo Fisher Scientific to introduce the CytoScan Automated Interpretation and Reporting (AIR) solution. This tool is expected to ease cytogenetic research data analysis.

Molecular Cytogenetics Market Report Highlights:

  • Based on application, the oncology segment dominated the market with a share of 39.70% in 2022, due to the capability of the CGH technology to avail detailed studies for cancer etiology
  • Based on product, consumables dominated the segment with a share of 39.51% in 2022, owing to the increasing knowledge and awareness regarding genetic diseases and personalized medicines
  • Based on technology, the comparative genomic hybridization segment dominated the market for molecular cytogenetics in 2022 due to the rising technological advancements for better chromosomal analysis
  • Based on end-use, the clinical & research laboratories segment held a majority of the revenue share in 2022. On the other hand, the pharmaceutical & biotech companies segment is anticipated to witness the fastest CAGR over the forecast period
  • In 2022, North America dominated the industry owing to the rising technological advancements, improving healthcare infrastructure, the presence of major players, and the increasing number of drug trials and their approvals in the region

Table of Contents

Chapter 1 Molecular Cytogenetics Market: Research Methodology And Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Application Segment
      • 1.1.1.2 Technology Segment
      • 1.1.1.3 Product Segment
      • 1.1.1.4 End Use Segment
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Abbreviations

Chapter 2 Molecular Cytogenetics Market: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Application And Technology Snapshot
  • 2.3 Product And End Use Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Molecular Cytogenetics Market: Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Rapid technological advancements
      • 3.2.1.2 Increasing prevalence of genetic disorders
      • 3.2.1.3 Growing application in oncology
      • 3.2.1.4 Increasing demand for personalized medicine
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Costs Of Testing
      • 3.2.2.2 Lack Of Reimbursement Policies
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 Pestel Analysis

Chapter 4 Molecular Cytogenetics Market: Application Business Analysis

  • 4.1 Molecular Cytogenetics Market: Application Movement Analysis
  • 4.2 Genetic Disorders
    • 4.2.1 Genetic Disorders Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Oncology
    • 4.3.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Personalized Medicine
    • 4.4.1 Personalized Medicine Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.5 Other Application
    • 4.5.1 Other Application Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Molecular Cytogenetics Market: Technology Business Analysis

  • 5.1 Molecular Cytogenetics Market: Technology Movement Analysis
  • 5.2 Comparative Genomic Hybridisation
    • 5.2.1 Comparative Genomic Hybridisation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 ACGH
      • 5.2.2.1 ACGH Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.3 SCGH
      • 5.2.3.1 SCGH Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Fish
    • 5.3.1 Fish Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Immunohistochemistry
    • 5.4.1 Immunohistochemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Karyotyping
    • 5.5.1 Karyotyping Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Spectral
      • 5.5.2.1 Spectral Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.3 Virtual
      • 5.5.3.1 Virtual Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Molecular Cytogenetics Market: Product Business Analysis

  • 6.1 Molecular Cytogenetics Market: Product Movement Analysis
  • 6.2 Instruments
    • 6.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Consumables
    • 6.3.1 Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Software & Services
    • 6.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Molecular Cytogenetics Market: End Use Business Analysis

  • 7.1 Molecular Cytogenetics Market: End Use Movement Analysis
  • 7.2 Clinical & Research Laboratories
    • 7.2.1 Clinical & Research Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Hospitals & Path Labs
    • 7.3.1 Hospitals & Path Labs Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Academic Research Institutes
    • 7.4.1 Academic Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Pharmaceutical & Biotech Companies
    • 7.5.1 Pharmaceutical & Biotech Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Others
    • 7.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Molecular Cytogenetics Market: Regional Business Analysis

  • 8.1 Regional Market Snapshot
  • 8.2 North America
    • 8.2.1 North America Molecular Cytogenetics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.2.2.2 Key Country Dynamics
      • 8.2.2.3 Regulatory Framework
      • 8.2.2.4 Reimbursement Scenario
    • 8.2.3 Canada
      • 8.2.3.1 Canada Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.2.3.2 Key Country Dynamics
      • 8.2.3.3 Regulatory Framework
      • 8.2.3.4 Reimbursement Scenario
  • 8.3 Europe
    • 8.3.1 Europe Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 UK Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.2.2 Key Country Dynamics
      • 8.3.2.3 Regulatory Framework
      • 8.3.2.4 Reimbursement Scenario
    • 8.3.3 Germany
      • 8.3.3.1 Germany Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.3.2 Key Country Dynamics
      • 8.3.3.3 Regulatory Framework
      • 8.3.3.4 Reimbursement Scenario
    • 8.3.4 Spain
      • 8.3.4.1 Spain Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.4.2 Key Country Dynamics
      • 8.3.4.3 Regulatory Framework
      • 8.3.4.4 Reimbursement Scenario
    • 8.3.5 France
      • 8.3.5.1 France Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.5.2 Key Country Dynamics
      • 8.3.5.3 Regulatory Framework
      • 8.3.5.4 Reimbursement Scenario
    • 8.3.6 Italy
      • 8.3.6.1 Italy Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.6.2 Key Country Dynamics
      • 8.3.6.3 Regulatory Framework
      • 8.3.6.4 Reimbursement Scenario
    • 8.3.7 Denmark
      • 8.3.7.1 Denmark Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.7.2 Key Country Dynamics
      • 8.3.7.3 Regulatory Framework
      • 8.3.7.4 Reimbursement Scenario
    • 8.3.8 Sweden
      • 8.3.8.1 Sweden Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.8.2 Key Country Dynamics
      • 8.3.8.3 Regulatory Framework
      • 8.3.8.4 Reimbursement Scenario
    • 8.3.9 Norway
      • 8.3.9.1 Norway Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.9.2 Key Country Dynamics
      • 8.3.9.3 Regulatory Framework
      • 8.3.9.4 Reimbursement Scenario
  • 8.4 Asia Pacific
    • 8.4.1 Asia-Pacific Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.2.2 Key Country Dynamics
      • 8.4.2.3 Regulatory Framework
      • 8.4.2.4 Reimbursement Scenario
    • 8.4.3 China
      • 8.4.3.1 China Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.3.2 Key Country Dynamics
      • 8.4.3.3 Regulatory Framework
      • 8.4.3.4 Reimbursement Scenario
    • 8.4.4 India
      • 8.4.4.1 India Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.4.2 Key Country Dynamics
      • 8.4.4.3 Regulatory Framework
      • 8.4.4.4 Reimbursement Scenario
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.5.2 Key Country Dynamics
      • 8.4.5.3 Regulatory Framework
      • 8.4.5.4 Reimbursement Scenario
    • 8.4.6 Thailand
      • 8.4.6.1 Thailand Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.6.2 Key Country Dynamics
      • 8.4.6.3 Regulatory Framework
      • 8.4.6.4 Reimbursement Scenario
    • 8.4.7 Australia
      • 8.4.7.1 Australia Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.7.2 Key Country Dynamics
      • 8.4.7.3 Regulatory Framework
      • 8.4.7.4 Reimbursement Scenario
  • 8.5 Latin America
    • 8.5.1 Latin America Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.5.2.2 Key Country Dynamics
      • 8.5.2.3 Regulatory Framework
      • 8.5.2.4 Reimbursement Scenario
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.5.3.2 Key Country Dynamics
      • 8.5.3.3 Regulatory Framework
      • 8.5.2.4 Reimbursement Scenario
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.5.4.2 Key Country Dynamics
      • 8.5.4.3 Regulatory Framework
      • 8.5.4.4 Reimbursement Scenario
  • 8.6 MEA
    • 8.6.1 MEA Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.6.2.2 Key Country Dynamics
      • 8.6.2.3 Regulatory Framework
      • 8.6.2.4 Reimbursement Scenario
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.6.3.2 Key Country Dynamics
      • 8.6.3.3 Regulatory Framework
      • 8.6.3.4 Reimbursement Scenario
    • 8.6.4 UAE
      • 8.6.4.1 UAE Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.6.4.2 Key Country Dynamics
      • 8.6.4.3 Regulatory Framework
      • 8.6.2.4 Reimbursement Scenario
    • 8.6.5 Kuwait
      • 8.6.5.1 Kuwait Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.6.5.2 Key Country Dynamics
      • 8.6.5.3 Regulatory Framework
      • 8.6.5.4 Reimbursement Scenario

Chapter 9 Molecular Cytogenetics Market: Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Strategy Mapping
    • 9.2.1 New product launch
    • 9.2.2 Partnerships
    • 9.2.3 Acquisition
    • 9.2.4 Collaboration
    • 9.2.5 Funding
  • 9.3 Company Market Share Analysis, 2022
  • 9.4 Company Profiles
    • 9.4.1 BIOVIEW
      • 9.4.1.1 Company overview
      • 9.4.1.2 Financial performance
      • 9.4.1.3 Product benchmarking
      • 9.4.1.4 Strategic initiatives
    • 9.4.2 DANAHER
      • 9.4.2.1 Company overview
      • 9.4.2.1.1 Leica Biosystems Nussloch GmbH
      • 9.4.2.2 Financial performance
      • 9.4.2.3 Product benchmarking
      • 9.4.2.4 Strategic initiatives
    • 9.4.3 METASYSTEMS
      • 9.4.3.1 Company overview
      • 9.4.3.2 Financial performance
      • 9.4.3.3 Product benchmarking
      • 9.4.3.4 Strategic initiatives
    • 9.4.4 AGILENT TECHNOLOGIES, INC.
      • 9.4.4.1 Company overview
      • 9.4.4.2 Financial performance
      • 9.4.4.3 Product benchmarking
      • 9.4.4.4 Strategic initiatives
    • 9.4.5 ABBOTT
      • 9.4.5.1 Company overview
      • 9.4.5.2 Financial performance
      • 9.4.5.3 Product benchmarking
      • 9.4.5.4 Strategic initiatives
    • 9.4.6 BIO-RAD LABORATORIES, INC.
      • 9.4.6.1 Company overview
      • 9.4.6.2 Financial performance
      • 9.4.6.3 Product benchmarking
      • 9.4.6.4 Strategic initiatives
    • 9.4.7 ILLUMINA, INC.
      • 9.4.7.1 Company overview
      • 9.4.7.2 Financial performance
      • 9.4.7.3 Product benchmarking
      • 9.4.7.4 Strategic initiatives
    • 9.4.8 OXFORD GENE TECHNOLOGY
      • 9.4.8.1 Company overview
      • 9.4.8.2 Financial performance
      • 9.4.8.3 Product benchmarking
      • 9.4.8.4 Strategic initiatives
    • 9.4.9 F. HOFFMANN-LA ROCHE LTD
      • 9.4.9.1 Company overview
      • 9.4.9.1.1 Genentech, Inc.
      • 9.4.9.2 Financial performance
      • 9.4.9.4 Product benchmarking
      • 9.4.9.5 Strategic initiatives
    • 9.4.10 PERKINELMER INC.
      • 9.4.10.1 Company overview
      • 9.4.10.2 Financial performance
      • 9.4.10.3 Product benchmarking
      • 9.4.10.4 Strategic initiatives
    • 9.4.11 QUEST DIAGNOSTICS INCORPORATED
      • 9.4.11.1 Company overview
      • 9.4.11.1.1 Sonora Quest Laboratories
      • 9.4.11.2 Financial performance
      • 9.4.11.3 Product benchmarking
      • 9.4.11.4 Product benchmarking
      • 9.4.11.5 Strategic initiatives
    • 9.4.12 APPLIED SPECTRAL IMAGING
      • 9.4.12.1 Company overview
      • 9.4.12.2 Financial performance
      • 9.4.12.3 Product benchmarking
      • 9.4.12.4 Strategic initiatives
    • 9.4.13 BIOLOGICAL INDUSTRIES USA, INC.
      • 9.4.13.1 Company overview
      • 9.4.13.2 Financial performance
      • 9.4.13.3 Product benchmarking
      • 9.4.13.4 Strategic initiatives
    • 9.4.14 CYTOTEST
      • 9.4.14.1 Company overview
      • 9.4.14.2 Financial performance
      • 9.4.14.3 Product benchmarking
      • 9.4.14.4 Strategic initiatives
    • 9.4.15 CYTOGNOMIX
      • 9.4.15.1 Company overview
      • 9.4.15.2 Financial performance
      • 9.4.15.3 Product benchmarking
    • 9.4.16 GENIAL GENETICS
      • 9.4.16.1 Company overview
      • 9.4.16.2 Financial performance
      • 9.4.16.3 Product benchmarking
      • 9.4.16.4 Strategic initiatives
    • 9.4.17 DIAGNOSTIC CYTOGENETICS, INC. (DCI)
      • 8.4.17.1 Company overview
      • 8.4.17.2 Financial performance
      • 8.4.17.3 Product benchmarking

Chapter 10 KOL Recommendations/Analyst Perspective

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 6. North America molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 7. North America molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 8. U.S. molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 10. U.S. molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 11. U.S. molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Canada molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 13. Canada molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 14. Canada molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 15. Canada molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Europe molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 17. Europe molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 18. Europe molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 19. Europe molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 20. Europe molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 21. UK molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 22. UK molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 23. UK molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 24. UK molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Germany molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 26. Germany molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 27. Germany molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 28. Germany molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 29. France molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 30. France molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 31. France molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 32. France molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Italy molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 34. Italy molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 35. Italy molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 36. Italy molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Spain molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 38. Spain molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 39. Spain molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 40. Spain molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 41. Denmark molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 42. Denmark molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 43. Denmark molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 44. Denmark molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 45. Sweden molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 46. Sweden molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 47. Sweden molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 48. Sweden molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Norway molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 50. Norway molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 51. Norway molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 52. Norway molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Asia Pacific molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 54. Asia Pacific molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 55. Asia Pacific molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 57. Asia Pacific molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 58. China molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 59. China molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 60. China molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 61. China molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 62. Japan molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 63. Japan molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 64. Japan molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 65. Japan molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 66. South Korea molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 67. South Korea molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 68. South Korea molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 69. South Korea molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Australia molecular cytogenetics market, by application 2018 - 2030 (USD Million)
  • Table 71. Australia molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 72. Australia molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 73. Australia molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 74. Thailand molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 75. Thailand molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 76. Thailand molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 77. Thailand molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 78. India molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 79. India molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 India molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 81. India molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 82. Latin America molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 83. Latin America molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 84. Latin America molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 85. Latin America molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 86. Latin America molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 87. Brazil molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 88. Brazil molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 89. Brazil molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 90. Brazil molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 91. Mexico molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 92. Mexico molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 93. Mexico molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 94. Mexico molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 95. Argentina molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 96. Argentina molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 97. Argentina molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 98. Argentina molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 99. Middle East & Africa molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 100. Middle East & Africa molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 101. Middle East & Africa molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 102. Middle East & Africa molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 103. Middle East & Africa molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 104. South Africa molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 105. South Africa molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 106. South Africa molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 107. South Africa molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 108. Saudi Arabia molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 109. Saudi Arabia molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 110. Saudi Arabia molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 111. Saudi Arabia molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 112. UAE molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 113. UAE molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 114. UAE molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 115. UAE molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 116. Kuwait molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 117. Kuwait molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 118. Kuwait molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 119. Kuwait molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Molecular cytogenetics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Segment snapshot
  • Fig. 12 Competitive landscape
  • Fig. 13 Molecular Cytogenetics Market Value, 2022 (USD Billion)
  • Fig. 14 Molecular Cytogenetics - Industry value chain analysis
  • Fig. 15 Molecular cytogenetics market dynamics
  • Fig. 16 Molecular cytogenetics market: PORTER's Five Forces analysis
  • Fig. 17 Molecular cytogenetics market: PESTEL analysis
  • Fig. 20 Molecular cytogenetics market: By application: Key takeaways
  • Fig. 21 Molecular cytogenetics market, by application: Market share, 2022 & 2030
  • Fig. 22 Genetic disorders market, 2018 - 2030 (USD Million)
  • Fig. 23 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 24 Personalized medicine market, 2018 - 2030 (USD Million)
  • Fig. 25 Other application market, 2018 - 2030 (USD Million)
  • Fig. 26 Molecular cytogenetics market: By technology: Key takeaways
  • Fig. 27 Molecular cytogenetics market, by technology: Market share, 2022 & 2030
  • Fig. 28 Comparative genomic hybridization market, 2018 - 2030 (USD Million)
  • Fig. 29 aCGH market, 2018 - 2030 (USD Million)
  • Fig. 30 sCGH market, 2018 - 2030 (USD Million)
  • Fig. 31 FISH market, 2018 - 2030 (USD Million)
  • Fig. 32 Immunohistochemistry market, 2018 - 2030 (USD Million)
  • Fig. 33 Karyotyping market, 2018 - 2030 (USD Million)
  • Fig. 34 Spectral market, 2018 - 2030 (USD Million)
  • Fig. 35 Virtual market, 2018 - 2030 (USD Million)
  • Fig. 36 Others market, 2018 - 2030 (USD Million)
  • Fig. 37 Molecular cytogenetics market: By product: Key takeaways
  • Fig. 38 Molecular cytogenetics market, by product: Market share, 2022 & 2030
  • Fig. 39 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 40 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 41 Software & services market, 2018 - 2030 (USD Million)
  • Fig. 42 Molecular cytogenetics market: By end use: Key takeaways
  • Fig. 43 Molecular cytogenetics market, by end use: Market share, 2022 & 2030
  • Fig. 44 Clinical & research laboratories market, 2018 - 2030 (USD Million)
  • Fig. 45 Hospitals & path labs market, 2018 - 2030 (USD Million)
  • Fig. 46 Academic research institutes market, 2018 - 2030 (USD Million)
  • Fig. 47 Pharmaceutical & biotech companies market, 2018 - 2030 (USD Million)
  • Fig. 48 Others market, 2018 - 2030 (USD Million)
  • Fig. 49 Molecular cytogenetics market revenue share, by region, 2022 & 2030 (USD Million)
  • Fig. 50 Regional marketplace: Key takeaways
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America: SWOT analysis
  • Fig. 53 North America molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Reimbursement procurement process
  • Fig. 56 U.S. molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Europe: SWOT analysis
  • Fig. 60 Europe molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Germany molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 UK molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 France molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Italy molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Spain molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Denmark molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Sweden molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Norway molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Asia Pacific: SWOT analysis
  • Fig. 78 Asia Pacific molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Reimbursement procurement process
  • Fig. 81 Japan molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 China molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 India molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Australia molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Korea molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Thailand molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America: SWOT analysis
  • Fig. 93 Latin America molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Brazil molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Mexico molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Argentina molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 MEA: SWOT analysis
  • Fig. 101 Middle East & Africa molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 South Africa molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Saudi Arabia molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 UAE molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Kuwait molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Key company categorization
  • Fig. 111 Company market position analysis
  • Fig. 112 Strategic framework